KEY WORDS: chronic liver disease; viral hepatitis; serum markers; modified Child-Turcotte-Pugh score
MELD score is a better prognostic model than Child-Turcotte-Pugh score
or Discriminant Function score in patients with alcoholic hepatitis.
varied from A5 to C11; most were classified as Child B (58%).
With respect to cirrhosis with complications, a placebo-controlled randomized trial showed a clinically relevant improvement in the Child-Turcotte-Pugh score
and a borderline significant reduction in the incidence of liver cancer with oral antiviral therapy.
With colchicine, 9% of patients showed improvement on their Child-Turcotte-Pugh score
during follow-up, 35% showed no change, and 56% showed disease progression.
Typically, the Child-Turcotte-Pugh score is used most often to predict survival in patients being considered for resection, said Dr.
The Child-Turcotte-Pugh score for the patients ranged from 5 to 9.
There appeared to be no correlation between the Child-Turcotte-Pugh score and death during surgery, said Dr.
However, slightly more patients on adefovir (67%) showed improvement, or no worsening, in their Child-Turcotte-Pugh scores
, compared with 61% of those on entecavir.
The Model for End-Stage Liver Disease (MELD), established in 2002, replaced the previous method of stratifying patients for transplant, which was based on waiting list time, Child-Turcotte-Pugh scores
, and hospital status (e.